Loading data for PBE — first visit, this takes a few seconds.

Invesco Biotechnology & G...

NYSEArca: PBE · Precio en tiempo real · USD
93.47
-0.75 (-0.80%)
Al cierre: Aug 14, 2026, 1:46 PM

Invesco Biotechnology & Genome ETF (PBE) ETF Price, Holdings & Analysis

-0.80%

No hay datos disponibles

Precio de compra93.05
Capitalización de mercadon/a
AUM281.95M
NAV93.86
Beta0.79
EPS (ttm)n/a
Relación PE (ttm)25.15
Acciones en circulación4.55M
Fecha de inicioJun 23, 2005
Precio de venta93.29
Volumen159
Volumen medio (20D)22,217
Abierto93.47
Cierre anterior94.22
Rango del día94.08 - 94.67
Rango de 52 semanas67.05 - 95.01
Participacionesn/a
Relación de gastos0.58%

Acerca de PBE

The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

Clase de activo Equity
Símbolo bursátil PBE
Fecha de inicio Jun 23, 2005
Proveedor Invesco
Intercambio NYSEArca

Sectores principales

Sector% en peso
Healthcare100.00%
Ver todos los sectores

Las 10 principales participaciones 46.14% de activos

NombreSímboloPeso
Regeneron Pharmaceut...REGN5.47%
Amgen IncAMGN5.22%
Caredx IncCDNA5.03%
Vertex Pharmaceutica...VRTX4.98%
Royalty Pharma PLC C...RPRX4.93%
Biogen IncBIIB4.78%
Gilead Sciences IncGILD4.43%
United Therapeutics ...UTHR4.07%
Bio-techne CorpTECH3.73%
Illumina IncILMN3.50%
Ver más participaciones

Dividendos Rendimiento de dividendos 1.66%

Ex-DividendoCantidadFecha de pago
Jun 22, 2026$0.8110n/a
Mar 23, 2026$0.0820n/a
Dec 22, 2025$0.4200n/a
Sep 22, 2025$0.2340n/a
Jun 23, 2025$0.1300n/a
Historial completo de dividendos